Altria Group Inc

MO

$38.99

-8.76% (1 year change)

Avg closing price

Price range

Market Cap

$73.5 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$5.06 Billion

Total revenue in the last quarter.

Net Income

$1.94 Billion

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$-0.49

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$3.36 (8.5%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-80.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$3.86 Billion

Earnings before interest expenses and taxes in the last quarter.

Employees

7,300

The number of full time employees.

Revenue & Earnings

Balance Sheet

Altria Group Inc

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Smokeless Products, and Wine. The Smokeable Products segment comprised of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Smokeless products segment manufactured and sold by or on behalf of USSTC and PM USA. The Wine segment producer of Washington State wines, primarily Chateau Ste. Michelle and Columbia Crest, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

News

North America Cancer Vaccines Market projected to reach US$ 6,626.6 million and Growing at a CAGR of 17.5% during forecast period 2020–2027, Key Players- AstraZeneca, GlaxoSmithKline plc., Aduro Biotech Inc, Pfizer Inc., Sanofi, Bristol-Myers Squibb, Mo

North America Cancer Vaccines Market projected to reach US$ 6,626.6 million and Growing at a CAGR of 17.5% during forecast period 2020–2027, Key Players- AstraZeneca, GlaxoSmithKline plc., Aduro Biotech Inc, Pfizer Inc., Sanofi, Bristol-Myers Squibb, Mo

North America cancer vaccines market was valued at US$ 1,875.7 million in 2019 and is projected to reach US$ 6,626.6 million by 2027; it is expected to grow at a CAGR of 17.5% during 2020–2027. Dem...

OpenPR OpenPR, 10 days ago
E-cigarette Market to Reach USD 29.53 Bn by 2024, Altria Group Inc. and British American Tobacco Plc Emerge as Key Contributor to Growth | Technavio

E-cigarette Market to Reach USD 29.53 Bn by 2024, Altria Group Inc. and British American Tobacco Plc Emerge as Key Contributor to Growth | Technavio

LONDON--(BUSINESS WIRE)-- #EcigaretteMarket--The Global E-cigarette Market will grow by USD 29.53 bn during 2020-2024

Business Wire Business Wire, 11 days ago
Insider Cannabis: The ultimate guide to legalization — Cannabis stocks soar — Columbia Care gears up for recreational pot

Insider Cannabis: The ultimate guide to legalization — Cannabis stocks soar — Columbia Care gears up for recreational pot

Summary List Placement Welcome to Insider Cannabis, our weekly newsletter where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cann...

Business Insider Business Insider, 14 days ago